Fluidra (FDR) Q3 2024 earnings summary

Executive summary

• Q3 2024 saw strong sales growth across all regions, led by North America and a return to growth in Europe after nine negative quarters, with Europe returning to positive growth for the first time since Q1 2022.

• Gross margin improved significantly, supported by the ongoing Simplification Program.

• Robust cash generation enabled a €161 million reduction in net debt year-over-year, with improved working capital.

• The company updated its full-year guidance, raising the midpoint for both sales and EBITDA.

• Recognition included being named Vendor of the Year for the fourth consecutive year by key U.S. distributors.

Financial highlights

• Sales for the first nine months reached €1,637 million, up 0.8% year-over-year; Q3 standalone sales grew 7.3%.

• EBITDA rose 6% year-over-year to €386 million, with a margin of 23.6%, up 110 basis points.

• Net profit increased to €123 million from €108 million in 2023; cash net profit was €194 million, up 8%.

• Gross margin reached 55.9%, 300 basis points higher than 2023, marking the sixth consecutive quarter of improvement.

• Net debt reduced by €161 million year-over-year to €1,069 million; leverage ratio improved to 2.3x from 2.9x.

Outlook and guidance

• Full-year 2024 guidance updated to €2,060–2,100 million in sales, €460–480 million EBITDA, and €1.14–1.20 cash EPS.

• Early buy campaign is ahead of last year, indicating strong customer confidence and positive Q1 visibility.

• Price increases for 2025 implemented: low- to mid-single digits in the U.S., 1–2% in Europe, expected to add 1–2% to topline.

• Restructuring and simplification-related charges to decline significantly in 2025 as the bulk of the program completes in 2024.

• Management remains confident in profitable growth and improving returns on capital.